← Open Payments lookup

HELEN SCOTT-BAYLEY: Open Payments

NPI 1316599145 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$336 in 14 payments from 9 companies in 2025. Trend: 2023 $310 · 2024 $163 · 2025 $336

Food & beverage: $336
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$130
Lilly USA, LLC2$52
Novo Nordisk Inc2$41
Dexcom, Inc.1$27
AstraZeneca Pharmaceuticals LP1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Bayer Healthcare Pharmaceuticals Inc.1$17
Exact Sciences Corporation1$16
Gilead Sciences, Inc.1$15

Products named: INGREZZA, MOUNJARO, DEXCOM G7 GSS (161), Ozempic, FARXIGA, CAPLYTA, Rybelsus, Kerendia.

Industry payments across MD — which companies pay providers there.